ネオアンチゲンターゲット治療の世界市場レポート 2023年以下を含む：1) タイプ別2）免疫療法タイプ別：DNAまたはRNAベースワクチン; タンパク質ベースワクチン; 樹状細胞ワクチン; TILベース療法3) 対象疾患別適応症別：対象疾患別: 大腸がん; 腎細胞がん; 非小細胞肺がん; 骨がん; 婦人科がん4) 投与経路別：皮内；静脈内；皮下5) 用途別医療研究機関；病院；クリニックCovering：F. Hoffmann-La Roche AG; Merck and Co.Inc.、Bristol Myers Squibb Company、GlaxoSmithKline plc、Eli Lilly and Company

Neoantigen Targeted Therapies Global Market Report 2023Including: 1) By Type: Monotherapy; Combination Therapy2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer4) By Route of Administration: Intradermal; Intravenous; Subcutaneous5) By Application: Medical Research Institution; Hospital; and ClinicCovering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company

The Business Research Companyのネオアンチゲンターゲット療法の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。当レポートは、力... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年9月21日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	175	英語

サマリー

The Business Research Companyのネオアンチゲンターゲット療法の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。

当レポートは、力強い成長を遂げている新抗原標的療法市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。

購入の理由
- 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。
- ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。
- 世界的な高インフレが市場成長に与える影響を測定する。
- 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。
- 最新の市場シェアに基づいて顧客を理解する。
- 主要な競合他社に対する業績のベンチマーク
- 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。
- レポートの全データは、エクセルのダッシュボード形式でも納品されます。

説明
ネオアンチゲン標的療法の最大かつ最速の成長市場はどこか？経済全体、人口動態、他の類似市場との関連は？今後どのような力が市場を形成していくのか？ビジネスリサーチ社のネオアンチゲン標的療法世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。

当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、動向、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。

調査範囲

対象市場：1）タイプ別単剤療法；併用療法
2) 免疫療法のタイプ別DNAまたはRNAベースワクチン；タンパク質ベースワクチン；樹状細胞ワクチン；TILベース療法
3) 標的疾患別適応症大腸がん；腎細胞がん；非小細胞肺がん；骨がん；婦人科がん
4) 投与経路別皮内投与、静脈内投与、皮下投与
5) 用途別医療研究機関、病院、クリニック、その他の用途

言及された企業F. ホフマン・ラ・ロシュ社、Merck and Co.Inc.、Bristol Myers Squibb Company、GlaxoSmithKline plc、Eli Lilly and Company

国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、

データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

納品形式PDF、Word、Excel データダッシュボード。

ページTOPに戻る

1. Executive Summary
2. Neoantigen Targeted Therapies Market Characteristics
3. Neoantigen Targeted Therapies Market Trends And Strategies
4. Neoantigen Targeted Therapies Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Neoantigen Targeted Therapies Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Neoantigen Targeted Therapies Market Segmentation
6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Monotherapy
Combination Therapy
6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
DNA Or RNA-Based Vaccines
Protein-Based Vaccines
Dendritic Cell Vaccines
TIL-Based Therapies
6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung Cancer
Bone Cancer
Gynecological Cancer
6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Intradermal
Intravenous
Subcutaneous
6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Medical Research Institution
Hospital And Clinic
Other Applications
7. Neoantigen Targeted Therapies Market Regional And Country Analysis
7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Neoantigen Targeted Therapies Market
8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Neoantigen Targeted Therapies Market
9.1. China Neoantigen Targeted Therapies Market Overview
9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Neoantigen Targeted Therapies Market
10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Neoantigen Targeted Therapies Market
11.1. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Neoantigen Targeted Therapies Market
12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Neoantigen Targeted Therapies Market
13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Neoantigen Targeted Therapies Market
14.1. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Neoantigen Targeted Therapies Market
15.1. Western Europe Neoantigen Targeted Therapies Market Overview
15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Neoantigen Targeted Therapies Market
16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Neoantigen Targeted Therapies Market
17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Neoantigen Targeted Therapies Market
18.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Neoantigen Targeted Therapies Market
19.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Neoantigen Targeted Therapies Market
20.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Neoantigen Targeted Therapies Market
21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview
21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Neoantigen Targeted Therapies Market
22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Neoantigen Targeted Therapies Market
23.1. North America Neoantigen Targeted Therapies Market Overview
23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Neoantigen Targeted Therapies Market
24.1. USA Neoantigen Targeted Therapies Market Overview
24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Neoantigen Targeted Therapies Market
25.1. Canada Neoantigen Targeted Therapies Market Overview
25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Neoantigen Targeted Therapies Market
26.1. South America Neoantigen Targeted Therapies Market Overview
26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Neoantigen Targeted Therapies Market
27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Neoantigen Targeted Therapies Market
28.1. Middle East Neoantigen Targeted Therapies Market Overview
28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Neoantigen Targeted Therapies Market
29.1. Africa Neoantigen Targeted Therapies Market Overview
29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles
30.1. Neoantigen Targeted Therapies Market Competitive Landscape
30.2. Neoantigen Targeted Therapies Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Merck and Co. Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Bristol Myers Squibb Company
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. GlaxoSmithKline plc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Eli Lilly and Company
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies
31.1. Kite Pharma Inc.
31.2. Gilead Sciences Inc.
31.3. Amgen Inc.
31.4. Moderna Inc.
31.5. BioNTech SE
31.6. Bavarian Nordic Inc.
31.7. Advaxis Inc.
31.8. Immatics NV
31.9. Precision Biologics Inc.
31.10. Iovance Biotherapeutics Inc.
31.11. Agenus Inc.
31.12. Achilles Therapeutics Plc
31.13. Medigene AG
31.14. Gritstone Bio Inc.
31.15. SQZ Biotechnologies Company
32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking
33. Global Neoantigen Targeted Therapies Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market
35. Neoantigen Targeted Therapies Market Future Outlook and Potential Analysis
35.1 Neoantigen Targeted Therapies Market In 2027 - Countries Offering Most New Opportunities
35.2 Neoantigen Targeted Therapies Market In 2027 - Segments Offering Most New Opportunities
35.3 Neoantigen Targeted Therapies Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

ページTOPに戻る

Table of Contents

Summary

Neoantigen Targeted Therapies Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neoantigen targeted therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for neoantigen targeted therapies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neoantigen targeted therapies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Type: Monotherapy; Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer
4) By Route of Administration: Intradermal; Intravenous; Subcutaneous
5) By Application: Medical Research Institution; Hospital; and Clinic; Other Applications

Companies Mentioned: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Business Research Company　(TBRC)社の医療サービス分野での最新刊レポート

本レポートと同じKEY WORD（immunotherapy）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート

本レポートと同じKEY WORD（immunotherapy）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の医療サービス分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?